Researchers from Nestec, an R&D subsidiary of Nestlé, have developed and validated a multiplex real-time PCR method to simultaneously detect 47 targets to aid in identifying genetically modified organisms.
By Doug Macron
Groove Biopharma announced this week that it has closed a $6 million Series B round of financing, giving the company enough funds to operate through 2012.
GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.
